Cash And Equivalent Cambiamento Data
AbbVie USD 13.29B 4.53B 2023-09
Actinium Pharmaceuticals USD 82.98M 8.3M 2023-09
Agios Pharmaceuticals USD 88.2M 23.87M 2023-12
Alnylam Pharmaceuticals USD 812.69M 220.34M 2023-12
Amgen USD 10.94B 23.8B 2023-12
Arrowhead Research USD 58.22M 44.78M 2023-12
Astellas Pharma JPY 333.99B 227.49B 2023-09
AstraZeneca USD 4.87B 793M 2023-09
Bayer EUR 6.82B 2.33B 2023-09
Biogen USD 1.05B 1.24B 2023-12
Bristol-Myers Squibb USD 11.46B 3.95B 2023-12
Eli Lilly USD 2.38B 313.7M 2023-09
GlaxoSmithKline GBP 3.18B 37M 2023-09
Incyte USD 3.21B 13.85M 2023-12
J&J USD 3.5B 497M 2023-09
Merck USD 8.6B 2.94B 2023-09
Pfizer USD 3.15B 516M 2023-09
Roche Holding CHF 3.72B 1.27B 2023-06
Takeda JPY 318.05B 1.67B 2023-09
Teva Pharmaceutical Industries USD 2.25B 420M 2023-09
TG Therapeutics USD 217.51M 66.61M 2023-12



Spectrum Pharmaceuticals Cassa E Equivalenti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2024.